![]() | |
![]() | |
Pharmacokinetic data | |
---|---|
Bioavailability | solution (64–88%) compared with capsule (22–40%). |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H19FN2O3S |
Molar mass | 338.40 g·mol−1 |
3D model (JSmol) | |
| |
|
TilmacoxiborJTE-522 is a COX-2 inhibitor and is an effective chemopreventive agent against rat experimental liver fibrosis.[1]
![]() | This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |